Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer cell

Showing results (741-750 of 4,103) with videos related to

Pageof 411
Sort By:
Cancer Cell|June 16, 2021
Seroconversion rates following COVID-19 vaccination among patients with cancerAstha Thakkar, Jesus D Gonzalez-Lugo, Niyati Goradia, et al.
Cancer Cell|July 9, 2021
Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of cautionElizabeth A Griffiths, Brahm H Segal
Cancer Cell|July 14, 2021
Cavity macrophages stop anti-tumor T cellsPaulo C Rodriguez, Brian Ruffell
Cancer Cell|July 14, 2021
Oncogenic mutations drive intestinal cancer initiation through paracrine remodelingHelen H N Yan, April S Chan, Suet Yi Leung
Cancer Cell|July 9, 2024
Th9 Cells Represent a Unique Subset of CD4<sup>+</sup> T Cells Endowed with the Ability to Eradicate Advanced TumorsYong Lu, Qiang Wang, Gang Xue, et al.
Cancer Cell|January 1, 2026
When the methylome becomes the microscopeHoutan Noushmehr
Cancer Cell|January 1, 2026
Antigen-specific profiling identifies T-bet<sup>+</sup> melanoma-specific CD8<sup>+</sup> T cells associated with response to neoadjuvant PD-1 blockadeGuanning Wang, Daniel Yoon, Ajeya Nandi, et al.
Cancer Cell|October 11, 2020
Cytokine Storms in Cancer and COVID-19Casmir Turnquist, Bríd M Ryan, Izumi Horikawa, et al.
Cancer Cell|June 18, 2021
Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trialLajos Pusztai, Christina Yau, Denise M Wolf, et al.
Cancer Cell|July 8, 2022
Increased antibody titers and reduced seronegativity following fourth mRNA COVID-19 vaccination in patients with cancerSidse Ehmsen, Anders Asmussen, Stefan S Jeppesen, et al.
Pageof 411

Showing results (741-750 of 4,103) with videos related to

Sort By:
Pageof 411
Cancer Cell|June 16, 2021
Seroconversion rates following COVID-19 vaccination among patients with cancerAstha Thakkar, Jesus D Gonzalez-Lugo, Niyati Goradia, et al.
Cancer Cell|July 9, 2021
Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of cautionElizabeth A Griffiths, Brahm H Segal
Cancer Cell|July 14, 2021
Cavity macrophages stop anti-tumor T cellsPaulo C Rodriguez, Brian Ruffell
Cancer Cell|July 14, 2021
Oncogenic mutations drive intestinal cancer initiation through paracrine remodelingHelen H N Yan, April S Chan, Suet Yi Leung
Cancer Cell|July 9, 2024
Th9 Cells Represent a Unique Subset of CD4<sup>+</sup> T Cells Endowed with the Ability to Eradicate Advanced TumorsYong Lu, Qiang Wang, Gang Xue, et al.
Cancer Cell|January 1, 2026
When the methylome becomes the microscopeHoutan Noushmehr
Cancer Cell|January 1, 2026
Antigen-specific profiling identifies T-bet<sup>+</sup> melanoma-specific CD8<sup>+</sup> T cells associated with response to neoadjuvant PD-1 blockadeGuanning Wang, Daniel Yoon, Ajeya Nandi, et al.
Cancer Cell|October 11, 2020
Cytokine Storms in Cancer and COVID-19Casmir Turnquist, Bríd M Ryan, Izumi Horikawa, et al.
Cancer Cell|June 18, 2021
Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trialLajos Pusztai, Christina Yau, Denise M Wolf, et al.
Cancer Cell|July 8, 2022
Increased antibody titers and reduced seronegativity following fourth mRNA COVID-19 vaccination in patients with cancerSidse Ehmsen, Anders Asmussen, Stefan S Jeppesen, et al.
Pageof 411